VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) on
Wednesday announced that its wholly owned subsidiary, ABcann Medicinals Inc.,
has received notification of the advancement of its Kimmetts project to the
second phase of Health Canada’s review and approval process. According to the
update, the project is being developed as a hybrid outdoor cultivation site and
currently houses four Airstream Innovations(TM) environmental control shelters
with cultivation space of 86,000 square feet. “Our airhouses are expected to
capitalize on all the benefits and opportunities associated with growing
outdoors (low capital and production costs, environmentally sustainable) with
the added benefit of mitigating against the known challenges of producing
high-quality cannabis outdoors,” said Greg Yuristy, Director of Production for
Napanee Operations. “The airhouses are intended to provide protection from the
elements and a more consistent cultivation environment, and are expected to
result in greater yields and more consistent high quality product than can be
produced via outdoor growing. In addition, positive pressure keeps insects and
weeds out, eliminating the need for pesticides.”
To view the full press release, visit http://ibn.fm/WuVhS
About VIVO Cannabis(TM)
VIVO, based in Napanee, Ontario, is recognized for trusted,
premium cannabis products and services. It holds production and sales licenses
from Health Canada and operates world-class indoor cultivation facilities with
proprietary plant-growing technology at its Canna Farms facility in Hope, B.C.,
and at its Vanluven facility in Napanee, Ontario. VIVO has a collection of
premium brands targeting unique customer segments, including Beacon
Medical(TM), Fireside(TM), Canna Farms(TM) and Lumina(TM). The company is
significantly expanding its production capacity and distribution channels;
growing its domestic medical cannabis platform, including Harvest Medicine, its
patient-centric, highly scalable network of specialty medical cannabis clinics
and services; promoting production and cultivation innovation and pursuing
partnership and product development opportunities; and actively focusing on
growth in select international markets, including Germany and Australia. VIVO
has a healthy balance sheet and is well-positioned to accelerate its growth in
Canada and internationally. For more information, visit the company’s website
at www.VivoCannabis.com.
NOTE TO INVESTORS: The latest news and updates
relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
